Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
AMAG:USNASDAQ GS

AMAG Pharmaceuticals Inc

COMPANY INFO
10.24USD
+0.20+1.99%
Market Closed
As of 05/24/2019 EDT
Open
10.14
Prev Close
10.04
Volume
762,833
Market Cap
345.773M
Day Range
9.9610.27
52 Week Range
9.8226.10
1D1M1Y5Y
View Full Chart
Market Closed
As of 05/24/2019 EDT
1D1M1Y5Y
View Full Chart
markets
Huawei CEO Pushes Back Against U.S. Ban
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio--
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding33.77M
Price to Book Ratio0.5622
Price to Sales Ratio0.8160
1 Year Return-56.79%
30 Day Avg Volume691,055
EPS-4.86
Bloomberg (BEst) EPS Curr Yr-2.3570
Dividend--
Last Dividend Reported--
Earnings Announcement for Period Ending Q1/2019:08/01/2019

Compare
1-Day Performance

-1%0+2%
-1%0+2%
Equity
AMAG:US
+1.99%
Sponsored By

About AMAG Pharmaceuticals Inc

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.
Address
1100 Winter Street Waltham, MA 02451 United States
Phone
1-617-498-3300
Website
www.amagpharma.com

Board Members

Name/Company
Gino Santini
James R Sulat
Valneva SE
Barbara H Deptula
View More
View More

Income Statement

Quarterly
Annual
;
Q1 2019 (Millions USD)
  • Revenue
    75.8
  • Net Income
    -122.1
  • Profit Margin
    -161.05%

Balance Sheet

Quarterly
Annual
;
Q1 2019 (Millions USD)
  • Total Assets
    1,072.9
  • Total Liabilities
    458.1
  • Debt to Assets
    25.49%

Cash Flow

Quarterly
Annual
Q1 2019 (Millions USD)
  • Operating
    -89.9
  • Investing
    11.3
  • Financing
    -36.8